Skip to main content
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: Vaccine. 2014 May 9;32(29):3617–3622. doi: 10.1016/j.vaccine.2014.04.083

Table 1.

In vivo experimental design.

Groups Number of piglets Vaccination (inactivated virus vaccines) Challenge virus (FL12)

1st 2nd
G1 3 + (FL12) +
G2 3 + (FL12) + (FL12) +
G3 3 + (FL12/GP5DM) +
G4 3 + (FL12/GP5DM) + (FL12/GP5DM) +
G5 3 +